scholarly journals E.5. Workshop: From spray campaigns to targeted strategies in infectious disease control: Bridging the gap between behavioural science and infectious disease controlOrganised by: EUPHA section Infectious diseases control

2018 ◽  
Vol 13 (4) ◽  
pp. 733-734
Author(s):  
Sumio Shinoda

The Science and Technology Research Partnership for Sustainable Development (SATREPS) is a Japanese government program that promotes international joint research. The program is structured as a collaboration between the Japan Science and Technology Agency (JST) and the Japan International Cooperation Agency (JICA). The program includes various fields, such as Environment and Energy, Bioresources, Disaster Prevention and Mitigation, and Infectious Disease Control, and a total 52 projects were currently in progress as of May, 2018. It is expected that the promotion of international joint research under this program will enable Japanese research institutions to conduct research more effectively in fields and having targets that make it advantageous to do that research in developing countries, including countries in Latin America and the Caribbean, Asia, and Africa. Recently, SATREPS projects in the field of Infectious Disease have been but under the control of the Japan Agency for Medical Research and Development (AMED). Although adult maladies, such as malignant tumors, heart disease, and cerebral apoplexy, are major causes of death in the developed countries including Japan, infectious diseases are still responsible for the high mortality rates in developing countries. Therefore, Infectious Disease Control is the important field of SATREPS. Infectious Disease Control projects are progressing in several countries, including Kenya, Zambia, Bangladesh, the Philippines, and Brazil, and various infectious diseases and pathogens have been targeted. In this special issue on Infectious Disease Control, the following reports from three projects have been selected: “The JICA-AMED SATREPS Project to Control Outbreaks of Yellow Fever and Rift Valley Fever in Kenya” by Nagasaki University, “Comprehensive Etiological and Epidemiological Study on Acute Respiratory Infections in Children in the Philippines” by Tohoku University, and “International Joint Research on Antifungal Resistant Fungi in Brazil” by Chiba University. These projects include viral, bacterial, and fungal infections. If they become available, further supplementary reports from other projects in this field will be published in a future issue.


PEDIATRICS ◽  
1973 ◽  
Vol 52 (2) ◽  
pp. 315-315
Author(s):  
Edward A. Mortimer

This new edition of a well-known text begins with approximately 100 pages of general information regarding immunity, epidemiology, preventive measures, and chemotherapy in infectious disease. This section is useful because most of it is succinct and accurate, and gives the reader an overall view of certain important aspects of infectious disease control. The part on chemotherapy is excellent but it is lengthy and detailed, and therefore serves more as a reference than as a chapter one would sit down to read in an evening.


2021 ◽  
pp. 597-622
Author(s):  
Robert J. Kim-Farley

Infectious diseases remain a leading cause of morbidity, disability, and mortality worldwide. Lower respiratory infections are the third leading causes of death worldwide and their control is a constant challenge that faces health workers and public health officials in both industrialized and developing countries. This chapter provides a global and comprehensive view of the principles of infectious disease control through examination of the magnitude of disease burden, the chain of infection (agent, transmission, and host) of infectious diseases, the varied approaches to their prevention and control (measures applied to the host, vectors, infected humans, animals, environment, and agents), and the factors conducive to their eradication as well as emergence and re-emergence.


Author(s):  
Wendy E. Parmet

This chapter explores the key features of American infectious disease law. The history of health law in the United States begins with the colonial laws that responded to the epidemics of smallpox, yellow fever, and other infectious diseases that regularly devastated the North American colonies. In the twentieth century, as the fear of infection declined, courts began to provide greater protections for individuals and vulnerable populations subjected to infectious disease laws. Moreover, the federal government began to play a more prominent and complex role in the control of infectious diseases. The chapter then looks at the allocation of authority between the states and federal government with respect to infectious disease control. It also discusses the role that restraint on individual rights plays in infectious disease control and the limits that the US Constitution and civil rights laws place on such restraints. The chapter also considers some of the specific tools that jurisdictions employ in response to infectious disease. It concludes with a brief discussion of the United States' role in global public health.


2021 ◽  
Author(s):  
◽  
Joshua McIvor

<p>Ebola virus disease (EVD) devastated its way into news headlines in 2014, destroying communities across three West African countries and costing the lives of over 11,000 people. The global health response was widely scrutinised and criticised, and though the outbreak is now over, there are still many lessons that can be learned from the 2014 EVD outbreak. This thesis will use the EVD outbreak in two ways. Firstly, I will use the EVD outbreak as a case study through which I will strive to address the ethical concerns for using experimental treatment during the outbreak, and I will address ethical concerns of the use of quarantine during the outbreak. Second, I will use the EVD outbreak as a launch pad to examine broader and more abstract ethical principles of the ethics of infectious disease control, such as the principles of reciprocity, transparency, proportionality, and the harm principle. This discussion will highlight how physical, biological features of a disease very much impact the application of the above principles when it comes to controlling the disease in an ethical manner. Finally, from this observation, I have created a ‘disease taxonomy’ that categorises infectious diseases based upon, what I argue, are the most ethically relevant biological features of infectious diseases. The taxonomy can aid in preparing for, understanding, and responding to the most pertinent ethical issues that surround various infectious diseases. The thesis should leave the reader with not only a greater understanding of some of the ethical issues raised by the 2014 EVD outbreak, but also a solid framework to utilise in discussing the most pertinent ethical issues of any future outbreak of any infectious disease.</p>


2021 ◽  
Author(s):  
◽  
Joshua McIvor

<p>Ebola virus disease (EVD) devastated its way into news headlines in 2014, destroying communities across three West African countries and costing the lives of over 11,000 people. The global health response was widely scrutinised and criticised, and though the outbreak is now over, there are still many lessons that can be learned from the 2014 EVD outbreak. This thesis will use the EVD outbreak in two ways. Firstly, I will use the EVD outbreak as a case study through which I will strive to address the ethical concerns for using experimental treatment during the outbreak, and I will address ethical concerns of the use of quarantine during the outbreak. Second, I will use the EVD outbreak as a launch pad to examine broader and more abstract ethical principles of the ethics of infectious disease control, such as the principles of reciprocity, transparency, proportionality, and the harm principle. This discussion will highlight how physical, biological features of a disease very much impact the application of the above principles when it comes to controlling the disease in an ethical manner. Finally, from this observation, I have created a ‘disease taxonomy’ that categorises infectious diseases based upon, what I argue, are the most ethically relevant biological features of infectious diseases. The taxonomy can aid in preparing for, understanding, and responding to the most pertinent ethical issues that surround various infectious diseases. The thesis should leave the reader with not only a greater understanding of some of the ethical issues raised by the 2014 EVD outbreak, but also a solid framework to utilise in discussing the most pertinent ethical issues of any future outbreak of any infectious disease.</p>


2021 ◽  
Author(s):  
Sima Ernest Rugarabamu

Close contact between people, animals, plants, and their shared environment provides more disease transmission opportunities. Host characteristics, environmental conditions, and habitat disruption can provide new opportunities for disease to occur. These changes may lead to the spread of existing and new diseases. Bacteria, viruses, fungi, protozoans, sporozoans, worms, and others cause infectious diseases. Some of these diseases may be prone to explosive outbreaks and may constitute deadly epidemic threats that could rapidly reach pandemic proportions. Drugs and vaccines can successfully control many infectious diseases; however, this is challenged by the lack of facilities and resources. In all parts of the world, infectious disease is an essential constraint to increased human, animal, and environmental interactions. Identifying hot-spot and interventions for prevention while considering the heterogeneity of target diseases to places, population time, or situation is essential. Therefore, successful infectious disease control measures must be based on understanding disease transmission pathways, strengthening surveillance systems, and intervention. Application of the One Health method is a responsive approach to infectious disease control. Much of the One-Health based approach to managing an infectious disease has been utilized with a promising effect on controlling current outbreaks. More deliberate efforts should encourage understanding of disease determinants to analyze infectious disease issues through a One-Health lens. Only through the extensive participation of all related field stakeholders can One-Health truly reach its potential to mitigate infectious disease outbreaks. This chapter reviews utilization of the One Health approach to infectious disease outbreak control.


Sign in / Sign up

Export Citation Format

Share Document